Liver Incytes System for Non-alcoholic Fatty Liver Disease

N/A

Waitlist Available

Research Sponsored by Sonic Incytes

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new ultrasound tool called the Liver Incytes system to measure liver stiffness in patients with liver disease. The device uses sound waves to create detailed images showing how stiff different parts of the liver are. The goal is to see how well this new tool works compared to existing methods.

Eligible Conditions

Non-alcoholic Fatty Liver Disease (NAFLD)
Non-alcoholic Fatty Liver Disease
Liver fibrosis
Fatty Liver Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Determination of Liver Incytes' discriminatory ability of liver stiffness as measured by fibrosis staging

Elasticity measurements comparison between Liver Incytes MR Elastography

Secondary study objectives

Liver extract

Comparison between Liver Incytes' and FibroScan's fibrosis staging capabilities

Comparison between Liver Incytes' and FibroScan's steatosis staging capabilities

+2 more

Other study objectives

Identification of cases in which FibroScan may overestimate or underestimate fat content

Identification of cases in which FibroScan may overestimate or underestimate liver stiffness

Liver extract

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Open-labelExperimental Treatment1 Intervention

Volunteers who have agreed to participate in the study will have their liver scanned using the FibroScan, VE (Liver Incytes System) and MRE techniques.

Do I qualify?Apply below to find out